FDA Extends Policy Allowing Some Changes to Remote Monitoring Devices Without New 510(k) Submissions

Dennis Tosh
October 25, 2023 at 12:35 PM EST
Preserving a version of an enforcement policy established during the early days of the COVID-19 public health emergency (PHE), the FDA will continue to allow limited changes to the indications, functionality, hardware or software of some noninvasive remote monitoring devices used to support patient monitoring without prior submission of a premarket notification (510(k)) to the... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.